☆ 4.6 Meeting Abstract

Pre-treatment antibodies to infliximab and adalimumab are common but are not associated with anti-TNF treatment failure

JOURNAL OF CROHNS & COLITIS (2022)

Add to Collection

Journal

JOURNAL OF CROHNS & COLITIS
Volume 16, Issue -, Pages I256-I256

Publisher

OXFORD UNIV PRESS

Keywords

-

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.